Bristol-Myers Squibb BMY Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on the most recent quarter.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's quick ratio?
- Bristol-Myers Squibb (BMY) reported quick ratio of 1.3× in Q1 2026.
- How has Bristol-Myers Squibb's quick ratio changed year-over-year?
- Bristol-Myers Squibb's quick ratio increased by 9.3% year-over-year, from 1.2× to 1.3×.
- What is the long-term trend for Bristol-Myers Squibb's quick ratio?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's quick ratio has grown at a -6.1% compound annual growth rate (CAGR), from 5.9× to 4.6×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.